A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biology

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The FASEB Journal

• Publication date

  2002-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1096/fj.01-0551comPMID 11874978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiation of the mammary gland and susceptibility to carcinogenesis

  2005cited by this paper
• c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

  2001cited by this paper
• Sustained mammary gland‐directed, ponasterone A‐inducible expression in transgenic mice

  2000cited by this paper
• Reversibility of acute B-cell leukaemia induced by BCR–ABL1

  2000cited by this paper
• Developmental role of the SNF1-related kinase Hunk in pregnancy-induced changes in the mammary gland.

  2000cited by this paper
• Temporal, spatial, and cell type–specific control of Cre-mediated DNA recombination in transgenic mice

  1999cited by this paper
• Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands.

  1999cited by this paper
• The right time and place for molecular scissors

  1999cited by this paper
• "Cre"-ating mouse mutants-a meeting review on conditional mouse genetics.

  1999cited by this paper
• Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

  1996cited by this paper
• Identification of sequences in c-myc mRNA that regulate its steady-state levels

  1996cited by this paper
• Time-Sensitive Reversal of Hyperplasia in Transgenic Mice Expressing SV40 T Antigen

  1996cited by this paper
• Rodent models for the study of etiology, prevention and treatment of breast cancer.

  1995cited by this paper
• Conditional gene expression in secretory tissues and skin of transgenic mice using the MMTV‐LTR and the tetracycline responsive system

  1995cited by this paper
• Transcriptional activation by tetracyclines in mammalian cells.

  1995cited by this paper
• Incidence of female breast cancer among atomic bomb survivors, 1950-1985.

  1994cited by this paper
• Cholesterol and bile acids regulate cholesterol 7 alpha-hydroxylase expression at the transcriptional level in culture and in transgenic mice

  1994cited by this paper
• Endogenous hormones and breast cancer risk.

  1993cited by this paper
• Comparative study of human and rat mammary tumorigenesis.

  1990cited by this paper
• Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice

  1990cited by this paper
• Prolactin regulation of mouse mammary tumor virus (MMTV) expression in normal mouse mammary epithelium.

  1989cited by this paper
• Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.

  1988influential reference
• Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice.

  1988cited by this paper
• Postnatal Development of the Rodent Mammary Gland

  1987cited by this paper
• Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.

  1987cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.

  1987cited by this paper
• Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development.

  1986cited by this paper
• Characterization and cloning of the mRNAs specific for the lactating mouse mammary gland.

  1982cited by this paper
• Age at first birth and breast cancer risk.

  1970cited by this paper
• Influence of pregnancy and lactation on the incidence of mammary carcinoma induced with methylcholanthrene in female mice of the "IF" strain.

  1955cited by this paper

• EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticity.

  2026cites this paper
• Atypical Cell Cycle Regulation over Neural Stem Cell Expansion

  2025cites this paper
• Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain Dormancy.

  2025cites this paper
• CD44 Marks Dormant Tumor Cells After HER2 Inhibition in Breast Cancer Cells

  2025cites this paper
• Residual Breast Cancer Cells Co-opt SOX5-driven Endochondral Ossification to Maintain Dormancy

  2025cites this paper
• Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy

  2024cites this paper
• Different oncogenes and reproductive histories shape the progression of distinct premalignant clones in multistage mouse breast cancer models.

  2024cites this paper
• Insulin Receptor Loss Impairs Mammary Tumorigenesis in Mice

  2023cites this paper
• Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways

  2023cites this paper
• The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer.

  2023cites this paper
• Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression

  2023cites this paper
• PAQR8 promotes breast cancer recurrence and confers resistance to multiple therapies

  2023cites this paper
• B3GALT6 Promotes Dormant Breast Cancer Cell Survival and Recurrence by Enabling Heparan Sulfate-Mediated FGF Signaling

  2023cites this paper
• NR2F1 is a barrier to dissemination of early stage breast cancer cells.

  2022cites this paper
• Escape from breast tumor dormancy: The convergence of obesity and menopause

  2022cites this paper
• In Vivo Modeling of Tumor Heterogeneity for Immuno‐Oncology Studies: Failures, Improvements, and Hopes

  2022cites this paper
• Stromal p53 Regulates Breast Cancer Development, the Immune Landscape, and Survival in an Oncogene-Specific Manner.

  2022cites this paper
• Aberrant RET expression affects normal mammary gland post-lactation transition, enhancing cancer potential

  2022cites this paper
• PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development

  2022cites this paper
• Mesenchymal tumor cells drive adaptive resistance of Trp53−/− breast tumor cells to inactivated mutant Kras

  2022cites this paper
• Dual recombinase action in the normal and neoplastic mammary gland epithelium

  2021cites this paper
• Emergence of β1 integrin-deficient breast tumours from dormancy involves both inactivation of p53 and generation of a permissive tumour microenvironment

  2021cites this paper
• PTHrP Induces STAT5 Activation, Secretory Differentiation and Mammary Tumor Progression

  2021cites this paper
• Metabolic memory underlying minimal residual disease in breast cancer

  2021influential citation
• Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo

  2020influential citation
• Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer

  2020cites this paper
• Rheb1-Independent Activation of mTORC1 in Mammary Tumors Occurs through Activating Mutations in mTOR.

  2020cites this paper
• Efficient tissue-type specific expression of target genes in a tetracycline-controlled manner from the ubiquitously active Eef1a1 locus

  2020cites this paper
• How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective

  2019cites this paper
• Impact of obesity on breast cancer recurrence and minimal residual disease

  2019cites this paper
• Longitudinal monitoring of in-vivo mice mammary tumor progression using intravital fluorescence tomography and optical coherence tomography

  2019cites this paper
• Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.

  2019cites this paper
• A Multistage Murine Breast Cancer Model Reveals Long-Lived Premalignant Clones Refractory to Parity-Induced Protection

  2019cites this paper
• Novel Cell Cycle Regulation in Stem Cells; Implications in Reprogramming and Central Nervous System Development

  2018cites this paper
• The Wnt Signaling Landscape of Mammary Stem Cells and Breast Tumors.

  2018cites this paper
• Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition

  2018influential citation
• Plk1 overexpression suppresses tumor development by inducing chromosomal instability

  2018cites this paper
• Mouse Models of Breast Cancer: Deceptions that Reveal the Truth

  2017cites this paper
• Development and Diseases of the Collecting Duct System.

  2017cites this paper
• A bioluminescence reporter mouse that monitors expression of constitutively active β-catenin

  2017cites this paper
• Role of MAF in bone metastasis

  2017cites this paper
• Mouse models of metastasis: progress and prospects

  2017cites this paper
• REGULATION OF BREAST CANCER INITIATION AND PROGRESSION BY 14-3-3ZETA

  2016cites this paper
• STAT 3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis

  2016cites this paper
• Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer

  2016cites this paper
• Regulation of Olfactory Stem Cells and Neurogenesis by Primary Cilia and the Hedgehog Pathway.

  2016cites this paper
• Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.

  2016cites this paper
• Negative Selection and Chromosome Instability Induced by Mad2 Overexpression Delay Breast Cancer but Facilitate Oncogene-Independent Outgrowth

  2016cites this paper
• STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis.

  2016cites this paper
• Analysis of the function of the IGF1R during the development and therapy of colorectal cancer

  2016influential citation
• Translating Lung Function Genome-Wide Association Study (GWAS) Findings: New Insights for Lung Biology.

  2016cites this paper
• Stability of Doxycycline in Feed and Water and Minimal Effective Doses in Tetracycline-Inducible Systems.

  2016cites this paper
• The Relationship Between Dormant Cancer Cells and Their Microenvironment.

  2016cites this paper
• Foxa1 is essential for mammary duct formation

  2016influential citation
• Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice

  2015influential citation
• Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.

  2015cites this paper
• Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ

  2015cites this paper
• Mouse models of breast cancer.

  2015cites this paper
• A DNA vector system for MMTV-promoter-based , doxycycline-inducible transgene expression and verified by expressing Mst 4 gene ( 1 )

  2015influential citation
• PIK3CAH1047R and Her2 initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling

  2015cites this paper
• Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy.

  2015cites this paper
• ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells

  2015cites this paper
• Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors

  2015cites this paper
• Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential Mechanisms.

  2015cites this paper
• Insights into the role of connexins in mammary gland morphogenesis and function.

  2015cites this paper
• Mimicking chromosomal instability observed in cancer: a study in mouse embryonic fibroblasts

  2015cites this paper
• Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential

  2015cites this paper
• Primary Cilia on Horizontal Basal Cells Regulate Regeneration of the Olfactory Epithelium

  2015cites this paper
• PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.

  2014cites this paper
• SPSB 1 May Have MET Its Match during Breast Cancer Recurrence

  2014cites this paper
• Oncogene pathway activation in mammary tumors dictates FDG-PET uptake.

  2014cites this paper
• Defining the mechanisms of breast tumorigenesis in the context of chromosome instability and oncogene dependence

  2014cites this paper
• Oncogene pathway activation in mammary tumors dictates [ 18 F]-FDG-PET uptake

  2014cites this paper
• SPSB1 may have MET its match during breast cancer recurrence.

  2014cites this paper
• Modeling breast cancer dormancy and recurrence following oncogenic pathway inhibition

  2014cites this paper
• Heterogeneity in Mammary Cancer: Using Mouse Models to Investigate Tumor Subtype Origins and Interclonal Interactions

  2014cites this paper
• Genetically engineered ER a -positive breast cancer mouse models

  2014cites this paper
• Tetracycline-regulated mouse models of cancer.

  2014cites this paper
• Oestrogen receptor-alpha regulates non-canonical Hedgehog-signalling in the mammary gland.

  2014cites this paper
• A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis

  2014cites this paper
• Social isolation stress, obesity, and breast cancer risk in mice

  2014cites this paper
• Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of TGF-β.

  2014cites this paper
• Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.

  2014influential citation
• Functional analysis of the KDM5B demethylase : in vitro and in vivo studies

  2014cites this paper
• Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression

  2014influential citation
• SPSB1 promotes breast cancer recurrence by potentiating c-MET signaling.

  2014influential citation
• Deciphering the Functions of Ets2, Pten and p53 in Stromal Fibroblasts in Multiple Breast Cancer Models

  2013influential citation
• Ratiometric analysis in hyperpolarized NMR (I): test of the two‐site exchange model and the quantification of reaction rate constants

  2013cites this paper
• Lactate detection in inducible and orthotopic Her2/neu mammary gland tumours in mouse models

  2013cites this paper
• Determining the Role of Autophagy in HER2/neu-Induced Mammary Tumor Dormancy and Recurrence

  2013cites this paper
• INTERACTION BETWEEN BRK AND HER2 IN BREAST CANCER

  2013cites this paper
• Hunk negatively regulates c-myc to promote Akt-mediated cell survival and mammary tumorigenesis induced by loss of Pten

  2013cites this paper
• Pre-Clinical Modeling of Breast Cancer: Which Model to Choose?

  2013cites this paper
• Evidence for a multipotent mammary progenitor with pregnancy-specific activity

  2013influential citation
• P190B RhoGAP Overexpression in the Developing Mammary Epithelium Induces TGFβ-dependent Fibroblast Activation

  2013cites this paper
• RNAi Mouse Models of Breast Cancer Tumor Suppressor Genes

  2013cites this paper
• Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling.

  2013influential citation
• Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration

  2013cites this paper
• Therapeutics , Targets , and Chemical Biology Conditional Loss of ErbB 3 Delays Mammary Gland Hyperplasia Induced by Mutant PIK 3 CA without Affecting Mammary Tumor Latency , Gene Expression , or Signaling

  2013influential citation
• Mouse models of PIK3CA mutations: one mutation initiates heterogeneous mammary tumors

  2013cites this paper